COVID-19 AND THE MEDICAL SUPPLY CHAIN
The COVID-19 pandemic – and the unprecedented demand for medical goods among other items – has generated substantial discussion of supply chain resilience and re-shoring.
Please join Washington International Trade Administration (WITA) and WIIT-DC as we discuss the trade policy implications of proposed supply chain initiatives, unpack the complexity of global supply chains, and discuss the findings from a new study [csis.org] of COVID-related medical products.
- Meredith Broadbent, Senior Advisor, Center for Strategic and International Studies, and author of the paper, Covid-19 Demand Shock and Preparedness Response
- Catherine Mellor, Vice President, UPS
- Moderator: Maddison Abboud, Manager, Global Health, U.S. Chamber of Commerce